Skip to main content

Table 4 The classification performance of the LFDA-DNN using the MN dataset

From: Deep learning-based framework for the distinction of membranous nephropathy: a new approach through hyperspectral imagery

Comparisons

HBV-MN

IMN

OA (%)

AA (%)

Kappa

SVM

65.20

68.27

66.80

66.74

0.3347

ELM

61.85

71.62

66.94

66.74

0.3356

Alexnet

65.16

69.01

67.16

67.09

0.3418

Resnet20

80.17

68.31

73.99

74.24

0.4819

VGG19

79.70

85.72

82.84

82.71

0.6554

LFDA-SVM

94.28

88.35

91.19

91.31

0.8239

LFDA-ELM

94.92

84.58

89.54

89.75

0.7913

LFDA-Alexnet

92.00

96.00

94.09

94.00

0.8814

LFDA-Resnet20

96.88

91.72

94.19

94.30

0.8839

LFDA-VGG19

95.67

94.45

95.04

95.06

0.9006